Skip to main content

Table 5 The effects of the GMP policy on the production of group 1 and group 2 by ITS analysis

From: Longitudinal study of the impact of three major regulations on the Korean pharmaceutical industry in the last 30 years

Variable

Coefficient

SE

t

p

Control group

\(\beta_{0}\)

3 921 915

7 296 197

0.54

0.5936

\(\beta_{1}\)

1 121 879

1 873 490

0.6

0.5524

\(\beta_{2}\)

3 613 799

7 193 712

0.5

0.6179

\(\beta_{3}\)

−241 415

1 944 213

−0.12

0.9017

\(\beta_{4}\)

769 559

8 308 389

0.09

0.9266

\(\beta_{5}\)

−148 447

1 944 213

−0.08

0.9395

\(\beta_{6}\)

−1 645 401

11 149 497

−0.15

0.8834

\(\beta_{7}\)

3 412 147

3 974 273

0.86

0.3952

Treatment group

\(\beta_{8}\)

29 594 918

10 318 380

2.87

0.0063*

\(\beta_{9}\)

5 905 425

2 649 515

2.23

0.031*

\(\beta_{10}\)

−6 906 227

10 173 446

−0.68

0.5008

\(\beta_{11}\)

644 845

2 749 532

0.23

0.8157

\(\beta_{12}\)

67 319 195

11 749 837

5.73

 < 0.0001*

\(\beta_{13}\)

−7 534 099

2 749 532

−2.74

0.0088*

\(\beta_{14}\)

−20 685 531

15 767 771

−1.31

0.1964

\(\beta_{15}\)

11 963 845

5 620 471

2.13

0.0389*

  1. *p < 0.05 (two-tailed test)